Efficacy of olaparib combined to metronomic cyclophosphamide and metformin in patients with recurrent advanced/metastatic endometrial by molecular subtypes: ENDOLA phase I/II trial. Time course of ...
The NGI Zero Commons Fund provides grants to people who help build the digital commons. Because all projects are free and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results